Projects and grants

The projects currently in progress or completed at ARL include:

UK - programme COOPERATIO - Gastroenterology (2022-)

MPO - FV10380 Biotechnological research of the changes in bile acid spectra for improvement of lipid profile, lithogenicity of bile and pro-cancerogenic potential (C2P s.r.o.) (running in years 2016 – 2021)

MH – AZV- NV17-31670A Life style and cardiometabolic risk in Czech children and adolescents: cross-sectional and prospective study (Institute of Endocrinology) (2017 – 2020)

UK - programme PROGRESS - Q25/LF1/2 Complications of metabolic diseases (2017-2020)

GTH – Internal Research Project – Diagnostics and treatment of genetically determined disorders: the framework of Development of the research organization VZ MZO 00064165 (2012-) 

MPO – Departmental Programme TIP - FR-TI4/638 The development of novel drug formulation of nicotinic acid with extended release (C2P s.r.o.) (2012-2015) 

UK - programme PRVOUK - P25/LF1/2 Pathogenesis of the complications of metabolic diseases and its applicability in early diagnostis, therapy and prevention (2012-2016)

MH - IGA - NT11247 The role of protective factors, oxidative stress and inflammatory response in the development of nonalcoholic liver disease in patients with metabolic syndrome and the possibility of experimental modulation of liver damage. (2010 - 2013)

MH - IGA- NT12342 Nutrition, obesity and metabolic syndrome in children and adolescents – the effect on the metabolism of lipids and adipokines, the changes during the reduction régime (2011-2015)

MH - IGA- NT13199 Selected genetic and nutritional factors in the pathogenesis of metabolic syndrome – the role of polyunsaturated fatty acids. (2012 - 2015).

MH - IGA - NT13236 The effect of diverse composition of fatty acids in home parenteral nutrition on the metabolism of lipids and indices of inflammation: randomized clinical study. (2012 - 2015)

AS ČR - GA - P301/11/0226 The importance of adiponectin-AMPK axis for the effect of thiazolidinediones on insulin sensitivity in dependence on their dosage. (2011-2015).